T-cell Immunogenicity

T-Cell Immunogenicity is the capacity of a recombinant protein vaccine to elicit a specific adaptive immune response mediated by T lymphocytes through the activation and proliferation of CD4+ and/or CD8+ T cells against target antigens.

1K

Publications

65.5K

Citations

8.3K

Authors

1.7K

Institutions

Publications per year

2017–2026

287

Authors

8.3K

  1. AV
    Adrian V. S. Hill

    University of Oxford, United Kingdom

    28 publications · 4.6K citations

    24

    h-index

  2. SC
    Sarah C. Gilbert

    University of Oxford, United Kingdom

    22 publications · 4.1K citations

    20

    h-index

  3. TH
    Tomáš Hanke

    University of Oxford, United Kingdom

    17 publications · 1.3K citations

    15

    h-index

  4. AS
    Alessandro Sette

    La Jolla Institute for Immunology, United States

    16 publications · 2.5K citations

    15

    h-index

  5. DC
    David C. Montefiori

    Duke Medical Center, United States

    10 publications · 676 citations

    10

    h-index

1–5 of 8.3K

Venues

  1. Vaccine

    116 publications · 5.3K citations

    43

    h-index

  2. The Journal of Immunology

    JI · 71 publications · 5.4K citations

    41

    h-index

  3. Proceedings of the National Academy of Sciences

    PNAS · 29 publications · 4.7K citations

    29

    h-index

  4. Journal of Virology

    JVI · 44 publications · 2.6K citations

    29

    h-index

  5. The Journal of Infectious Diseases

    JID · 28 publications · 2.1K citations

    24

    h-index

1–5